CardioFocus Piles Up Data On <em>HeartLight </em>Laser AF Ablation Catheter

CardioFocus Piles Up Data On HeartLight Laser AF Ablation Catheter

20 May 2013

In addition to the more than 1,300 ablation procedures completed outside the U.S. with the unique visually guided ablation catheter, the venture-backed company is conducting an IDE trial in 21 U.S. centers, which it expects to complete in 2014.

CardioFocus Inc. is confident the growing set of data from experience with its HeartLight visually guided laser ablation balloon catheter will allow it to be competitive in the increasingly crowded U.S. atrial fibrillation (AF) ablation device market by 2015.

“The company has been very methodical in building a clinical story,” CardioFocus Executive Chairman Paul LaViolette told “The Gray Sheet.”